CrystalGenomics, Inc. announced a private placement of 4,382,470 redeemable convertible preferred shares at the price of KRW 5,020 per share for gross proceeds of KRW 21,999.9994 on June 13, 2022. The transaction will include participation from Hyundai Investment Partners S&H New Technology Business Fund. The company will issue shares of par value of KRW 500 per share through third party allocation increase method.

The shares will be locked up for a period of one year. The transaction has been approved by board of directors of the company. The payment date for the transaction is June 24, 2022.